These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 351960)

  • 41. A method for the automated screening for hepatitis B surface antigen.
    Kunitomo K; Saji H; Yahara S; Hosoi T
    Vox Sang; 1980 Oct; 39(4):215-21. PubMed ID: 7210611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. False reactions in radioimmunoassay for viral hepatitis B markers in patients suffering from coagulation disorders.
    Grangeot-Keros L; Lambert T; Dubreuil P; Briantais MJ; Pillot J
    Vox Sang; 1982 Mar; 42(3):160-3. PubMed ID: 6803440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term follow-up of Hepatitis B Surface antibody levels in subjects receiving universal Hepatitis B vaccination in infancy in an area of hyperendemicity: correlation between radioimmunoassay and enzyme immunoassay.
    Wang CW; Wang LC; Chang MH; Ni YH; Chen HL; Hsu HY; Chen DS
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1442-7. PubMed ID: 16339069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An automated screening test for antibodies to human immunodeficiency virus-1.
    Sekiguchi S; Ikeda H; Kato T; Maeda R; Fukai K
    Transfusion; 1988; 28(6):581-5. PubMed ID: 3057684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enzyme-linked immunoassay for hepatitis B surface antigen. An evaluation of commercial test kits.
    Nath N; Dodd RY; Fang CT
    Transfusion; 1983; 23(1):45-8. PubMed ID: 6829058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results. Retrovirus Epidemiology Donor Study.
    Ownby HE; Korelitz JJ; Busch MP; Williams AE; Kleinman SH; Gilcher RO; Nourjah P
    Transfusion; 1997 Feb; 37(2):199-205. PubMed ID: 9051096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of two techniques (RPHA and latex agglutination) for use as a screening tool for HBsAg.
    Ranga S; Pandey J; Talib VH
    Indian J Pathol Microbiol; 1994 Oct; 37(4):375-80. PubMed ID: 7868169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Which techniques should be used to screen blood donations for hepatitis B surface antigen?
    Wallace J; Barr A; Milne GR
    Br Med J; 1975 May; 2(5968):412-4. PubMed ID: 1125561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The detection of hepatitis B surface antigen by radioimmunoassay.
    Gust ID; Lehmann NI
    Pathology; 1975 Oct; 7(4):285-92. PubMed ID: 1223718
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Solid-phase enzyme immunoassay for hepatitis B surface antigen.
    Wei R; Knight GJ; Zimmerman DH; Bond HE
    Clin Chem; 1977 May; 23(5):813-5. PubMed ID: 322892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved economics of HBsAg screening with commercial radioimmunoassay reagents.
    Hopkins R; Ross S; Jordan T; Watt AD
    J Clin Pathol; 1980 Jan; 33(1):19-23. PubMed ID: 6987272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda.
    Seremba E; Ocama P; Opio CK; Kagimu M; Yuan HJ; Attar N; Thomas DL; Lee WM
    J Med Virol; 2010 Aug; 82(8):1334-40. PubMed ID: 20572076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine.
    Aoki SK; Finegold D; Kuramoto IK; Douville C; Richards C; Randell R; Fernando L; Holland PV; Zeldis JB
    Transfusion; 1993 May; 33(5):362-7. PubMed ID: 8488537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
    Malm K; Kragsbjerg E; Andersson S
    Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis-associated markers in the American Red Cross volunteer blood donor population. ii. Distribution of level of HBsAg reactivity by radioimmunoassay and occurrence of nonspecific reactivity.
    Nath N; Fang CT; Berberian H; Bastiaans MJ; Dodd RY; Sandler SG; Barker LF
    Vox Sang; 1980 Aug; 39(2):73-8. PubMed ID: 7281597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevalence of Trypanosoma cruzi antibodies in blood donors].
    Blejer JL; Saguier MC; Dinapoli RA; Salamone HJ
    Medicina (B Aires); 1999; 59(2):129-32. PubMed ID: 10413888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
    Dogbe EE; Arthur F
    Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous use of poly- and monoclonal antibodies as enzyme tracers in a one-step enzyme immunoassay for the detection of hepatitis B surface antigen.
    Palomäki P
    J Immunol Methods; 1991 Dec; 145(1-2):55-63. PubMed ID: 1765666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversed passive hemagglutination test fails to detect HBsAg in a number of HBeAg positive sera.
    Thammanichanond D; Kunakorn M; Settaudom C; Khupulsup K
    Asian Pac J Allergy Immunol; 2002 Jun; 20(2):135-7. PubMed ID: 12403199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haemagglutination assay for HBsAg -- a new approach to reagent preparation.
    Hopkins R; Watt AD; Ross S
    J Immunol Methods; 1978; 20():35-41. PubMed ID: 649965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.